Exhibit 99.1


Pursuant to General Instruction number 5(b)(v) to Form 3, the following
additional reporting persons are covered by this joint filing:

Name:   Foresite Capital Fund II, L.P.
        Foresite Capital Management III, LLC
        Foresite Capital Fund III, L.P.

        Address:   Foresite Capital
                   600 Montgomery Street Street
                   Suite 4500
                   San Francisco, CA  94111

Name:   James B. Tananbaum

        Address:   3052 Pacific Avenue
                   San Francisco, CA  94115

Designated Filer:                 Foresite Capital Management II, LLC

Issuer and Ticker Symbol:         Aerie Pharmaceuticals, Inc. (AERI)

Date of Event Requiring Statement:July 22, 2016


Each of the following is a Joint Filer with Foresite Capital Management II, LLC
("FCM II") and may be deemed to share indirect beneficial ownership in the
securities set forth on the attached Form 3:

FCM II is the general partner of Foresite Capital Fund II, L.P. ("FCF II").  As
such, FCM II possesses sole voting and investment control over the shares owned
by FCF II, and may be deemed to have indirect beneficial ownership of the
securities held by FCF II, however, owns no shares of the Issuer directly.  Mr.
Tananbaum is the managing member of FCM II and in his capacity as such, may be
deemed to exercise sole voting, investment and dispositive power over the
shares held by FCF II.  FCM III is the general partner of Foresite Capital Fund
III, L.P. ("FCF III").  As such, FCM III possesses sole voting and investment
control over the shares owned by FCF III, and may be deemed to have indirect
beneficial ownership of the securities held by FCF III, however, owns no shares
of the Issuer directly.  Mr. Tananbaum is the managing member of FCM III and in
his capacity as such, may be deemed to exercise sole voting, investment and
dispositive power over the shares held by FCF III.  Each Reporting Person
disclaims beneficial ownership of the shares held by FCF II and FCF III except
to the extent of his or its proportionate pecuniary interest therein.  The
filing of this statement shall not be deemed an admission that, for purposes of
Section 16 of the Securities Exchange Act of 1934, or otherwise, any of the
Reporting Persons are the beneficial owners of all of the equity securities
covered by this statement.

Each of the Reporting Persons listed above hereby designates FCM II as its
designated filer of Forms 3, 4 and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934 and the rules thereunder.


FORESITE CAPITAL MANAGEMENT II, LLC

By:     /s/ Dennis D. Ryan
        --------------------------------
        Dennis D. Ryan
        Chief Financial Officer


FORESITE CAPITAL FUND II, L.P

By:     Foresite Capital Management II, LLC
        Its General Partner

By:     /s/ Dennis D. Ryan
        --------------------------------
        Dennis D. Ryan
        Chief Financial Officer


FORESITE CAPITAL MANAGEMENT III, LLC

By:     /s/ Dennis D. Ryan
        --------------------------------
        Dennis D. Ryan
        Chief Financial Officer


FORESITE CAPITAL FUND III, L.P

By:     Foresite Capital Management III, LLC
        Its General Partner

By:     /s/ Dennis D. Ryan
        --------------------------------
        Dennis D. Ryan
        Chief Financial Officer


  /s/ James B. Tananbaum
----------------------------------------
James B. Tananbaum